Blog2024-07-01T14:28:28-05:00

Sleep Medicine Weekly Insider – May 27, 2023

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. SLEEP begins in one week: Register now! It’s time to “Refuel at SLEEP 2023!” [...]

May 27th, 2023|Weekly Insider|

FDA approves remedē System for MRI conditional use

On May 24, 2023, Zoll announced the FDA has approved the remedē System for conditional use with magnetic resonance imaging (MRI). The implantable transvenous phrenic nerve stimulation therapy is a treatment for adults with moderate to severe central sleep [...]

May 25th, 2023|Industry|

Sleep Medicine Weekly Insider – May 20, 2023

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Philips PAP device recall update Philips posted a press release announcing completed testing results [...]

May 20th, 2023|Weekly Insider|

Sleep Medicine Weekly Insider – May 13, 2023

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. AASM advocates for Blue Shield changes After several members reported Blue Shield of California [...]

May 13th, 2023|Weekly Insider|

Sleep Medicine Weekly Insider – May 6, 2023

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Avadel receives FDA approval for Lumryz Avadel Pharmaceuticals announced that the FDA has granted [...]

May 6th, 2023|Weekly Insider|

FDA clears Cumulus dry-sensor EEG headset

Cumulus Neuroscience announced on May 4, 2023, that its dry-sensor electroencephalograph (EEG) headset has received FDA 510(k) clearance. The device is FDA-cleared for use in adults and adolescents for the remote acquisition, display and storage of EEG data. [...]

May 5th, 2023|Industry|

Avadel receives FDA approval for Lumryz

Avadel Pharmaceuticals announced on May 1, 2023 that the FDA granted final approval to Lumryz, an extended-released sodium oxybate medication. It is taken once at bedtime for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. [...]

May 2nd, 2023|Industry|

Sleep Medicine Weekly Insider – April 29, 2023

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Melatonin content varies in gummies A new research letter published in JAMA reports that [...]

April 29th, 2023|Weekly Insider|

AASM names gold standard panel of manual scorers

The AASM has created a gold standard of sleep records to validate third party automated sleep scoring algorithms for the Autoscoring Certification: Sleep Stage Pilot Program. The goal of this project is to establish objective performance requirements for [...]

April 26th, 2023|Industry|
Go to Top